Medical oncology and tumor pharmacotherapy
Reizenstein P.
PMID: 3441151
Med Oncol Tumor Pharmacother. 1987;4(3):121-3. doi: 10.1007/BF02934507.
No abstract available.
Cite
Reizenstein P. Cancer risks in perspective. Med Oncol Tumor Pharmacother. 1987;4(3):121-3doi: 10.1007/BF02934507.
Reizenstein, P. (1987). Cancer risks in perspective. Medical oncology and tumor pharmacotherapy, 4(3), 121-3. https://doi.org/10.1007/BF02934507
Reizenstein, P. "Cancer risks in perspective." Medical oncology and tumor pharmacotherapy vol. 4,3 (1987): 121-3. doi: https://doi.org/10.1007/BF02934507
Reizenstein P. Cancer risks in perspective. Med Oncol Tumor Pharmacother. 1987;4(3):121-3. doi: 10.1007/BF02934507. PMID: 3441151.
Copy
Download .nbib
Medical oncology and tumor pharmacotherapy
Reizenstein P.
PMID: 3412037
Med Oncol Tumor Pharmacother. 1988;5(2):75-6.
No abstract available.
Cite
Reizenstein P. Pergamon Press--40 years. Med Oncol Tumor Pharmacother. 1988;5(2):75-6
Reizenstein, P. (1988). Pergamon Press--40 years. Medical oncology and tumor pharmacotherapy, 5(2), 75-6.
Reizenstein, P. "Pergamon Press--40 years." Medical oncology and tumor pharmacotherapy vol. 5,2 (1988): 75-6.
Reizenstein P. Pergamon Press--40 years. Med Oncol Tumor Pharmacother. 1988;5(2):75-6. PMID: 3412037.
Copy
Download .nbib
Medical oncology and tumor pharmacotherapy
Bailar JC, Smith EM.
PMID: 3326981
Med Oncol Tumor Pharmacother. 1987;4(3):193-8. doi: 10.1007/BF02934515.
We have examined trends in cancer mortality, incidence and survival in the United States to update our earlier work and respond to criticisms. [Bailar, J.C., Smith, E.M.: New Engl. J. Med. 314, 1226 (1986).] Here we concentrate on the...
Cite
Bailar JC, Smith EM. Have we reduced the risk of getting cancer or of dying from cancer? An update. Med Oncol Tumor Pharmacother. 1987;4(3):193-8doi: 10.1007/BF02934515.
Bailar, J. C., & Smith, E. M. (1987). Have we reduced the risk of getting cancer or of dying from cancer? An update. Medical oncology and tumor pharmacotherapy, 4(3), 193-8. https://doi.org/10.1007/BF02934515
Bailar, J C, and Smith, E M. "Have we reduced the risk of getting cancer or of dying from cancer? An update." Medical oncology and tumor pharmacotherapy vol. 4,3 (1987): 193-8. doi: https://doi.org/10.1007/BF02934515
Bailar JC, Smith EM. Have we reduced the risk of getting cancer or of dying from cancer? An update. Med Oncol Tumor Pharmacother. 1987;4(3):193-8. doi: 10.1007/BF02934515. PMID: 3326981.
Copy
Download .nbib
Medical oncology and tumor pharmacotherapy
[No authors listed]
PMID: 3441150
Med Oncol Tumor Pharmacother. 1987;4(3):121-276.
No abstract available.
Cite
Assessment and management of cancer risks. Papers presented at a Symposium on Cancer Risks. Stockholm, 21-22 May 1987. Med Oncol Tumor Pharmacother. 1987;4(3):121-276
(1987). Assessment and management of cancer risks. Papers presented at a Symposium on Cancer Risks. Stockholm, 21-22 May 1987. Medical oncology and tumor pharmacotherapy, 4(3), 121-276.
"Assessment and management of cancer risks. Papers presented at a Symposium on Cancer Risks. Stockholm, 21-22 May 1987." Medical oncology and tumor pharmacotherapy vol. 4,3 (1987): 121-276.
Assessment and management of cancer risks. Papers presented at a Symposium on Cancer Risks. Stockholm, 21-22 May 1987. Med Oncol Tumor Pharmacother. 1987;4(3):121-276. PMID: 3441150.
Copy
Download .nbib
